Cargando…
Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression
BACKGROUND: Chronic rhinosinusitis (CRS) has a high prevalence of anxiety and depression. It is currently uncertain if treatment in patients with CRS with or without nasal polyps (CRSwNP and CRSsNP) has any impact on improving mental health outcomes. The aims here were to document anxiety and depres...
Autores principales: | Vogt, Florian, Sahota, Jagdeep, Bidder, Therese, Livingston, Rebecca, Bellas, Helene, Gane, Simon B., Lund, Valerie J., Robinson, Douglas S., Kariyawasam, Harsha H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099201/ https://www.ncbi.nlm.nih.gov/pubmed/33900051 http://dx.doi.org/10.1002/clt2.12002 |
Ejemplares similares
-
Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020) -
Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps
por: Kariyawasam, Harsha H, et al.
Publicado: (2020) -
Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps
por: Novosad, Jakub, et al.
Publicado: (2020) -
Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022) -
Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps
por: Chen, Jiun-Bo, et al.
Publicado: (2017)